News

PMLive35m
Regeneron’s bispecific antibody Lynozyfic approved by EC to treat multiple myeloma
Regeneron Pharmaceuticals’ Lynozyfic (linvoseltamab) has been granted conditional marketing approval by the European ...
PMLive36m
MHRA approves Autolus Therapeutics’ Aucatzyl to treat acute lymphoblastic leukaemia
The Medicines and Healthcare products Regulatory Agency (MHRA) has granted conditional marketing authorisation to Autolus ...
PMLive38m
Takeda receives CHMP recommendation for Adcetris in Hodgkin lymphoma
The Committee for Medicinal Products for Human Use (CHMP) has recommended that the CD30-directed antibody-drug conjugate (ADC ...